REVIEW ARTICLE ON SUSTAINED RELEASE DELIVERY SYSTEM OF ANTI-PLATELET DRUGS
S
Shivesh Prasad Sinha
D
Dr.Manish Jaimini
Abstract
Antiplatelet medications currently on the market interfere with one or more phases in the platelet release and aggregation process, leading to a meaningful decrease in thrombosis risk that cannot be separated from an elevated risk of bleeding. Understanding that under physiological conditions, 1011 platelets are created daily-a quantity that can rise up to 10-fold during times of greater need—is crucial when thinking about antiplatelet medications.
Article Details
Volume / Issue
Vol. 9, Issue 5
Published
October 29, 2022
Pages
37-44
Publisher
Jadoun Science Publishing Group
Journal Info
Tropical Journal of Pharmaceutical and Life Sciences
Jadoun Science Publishing Group
Open Access Medical Sciences
Authors (2)
S
Shivesh Prasad Sinha
D
Dr.Manish Jaimini
Related Articles from this Journal
Traditional Knowledge and Molecular Evidence of Medicinal Plants for Multi-Target Dengue Therapy: A Review
Mohammed Anas, Farhat Jahan
Aug 2026
10.61280/tjpls.v13i4.306
Occurrence and Severity of Chemotherapy-Induced Peripheral Neuropathy and Its Association with Comorbidities in Patients Receiving Cytotoxic Chemotherapy: A Prospective Observational Study
Mandeep Singh Juneja, Nandhana Rajesh et al.
Aug 2026
10.61280/tjpls.v13i4.311
A Study to Assess Risk Stratification by Using Child-Pugh Score, Rate of Admission and Management Strategies of Inpatients with Alcoholic Liver Disease
Sunny Jaiswal, Susmita Malakar et al.
Aug 2026
10.61280/tjpls.v13i4.305
Deciphering the Insulin Link: Exploring Metabolic Interplay in Polycystic Ovary Syndrome
Mudasir Maqbool, Zulfkar Qadrie et al.
Aug 2026
10.61280/tjpls.v13i4.285
A Study to Assess the Effectiveness of Self-Instructional Module on Knowledge Regarding Selected Rare Diseases in Children Among Nursing Officers Working at Selected Government Hospital Jaipur, Rajasthan
Tarun Swami
Jun 2026
10.61280/tjpls.v13i3.303